Source: Eur Respir Mon; 2006: 34: 50–68



Rating:

Share or cite this content

Citations should be made in the following way:
M. Thomeer, L. Harper, P. Heeringa, P. Saikku, C.O. Savage, E. Van Wijngaerden, E. Verbeken, G.M. Verleden, and the co-workers of Working Group 2. Classification and new developments in the pathogenesis of vasculitis. Eur Respir Mon; 2006: 34: 50–68

Member's Comments

No comment yet.

Related content which might interest you: Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69 Year: 2005 Alveolar haemorrhage syndromes Source: Eur Respir Mon 2011; 54: 15-31 Year: 2011 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Source: Eur Respir J 2016; 48: 1429-1441 Year: 2016 Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now? Source: Eur Respir J 2015; 46: 1255-1258 Year: 2015 Churg–Strauss syndrome Source: Eur Respir Mon 2011; 54: 140-151 Year: 2011 New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Granulomatosis with polyangiitis (Wegener&s) Source: Eur Respir Mon 2011; 54: 1-14 Year: 2011 c-ANCA-induced neutrophil-mediated lung injury: a model of acute Wegener's granulomatosis Source: Eur Respir J 2010; 36: 187-195 Year: 2010 Churg-Strauss's syndrome and eosinophilic polyserositis Source: Eur Respir J 2002; 20: Suppl. 38, 65s Year: 2002 Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) Source: Eur Respir J, 57 (5) 2004158; 10.1183/13993003.04158-2020 Year: 2021 Anca and anti-gbm-antibodies in pulmonary-renal syndrome due to Wegener‘s granulomatosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases Source: International Congress 2014 – ILDs 6 Year: 2014 Co-existence of eosinophilic granulomatosis with polyangiitis, HIV and HCV infection: A rare coincidence? Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 38: 1081-1088 Year: 2011 Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020 Year: 2020 ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Wegener's granulomatosis (WG) - clinical features and response to treatment in 18 cases Source: Eur Respir J 2002; 20: Suppl. 38, 64s Year: 2002